Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: A nationwide case-control study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 1, 2015, Pages 86-94

  Madsen, Cecilie ^a   Baandrup, Louise ^a   Dehlendorff, Christian ^a   Kjær, Susanne K ^a,b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

borderline ovarian tumor; histologic subtype; Ovarian cancer; salpingectomy; tubal ligation

Indexed keywords

ADULT; AGED; ARTICLE; BORDERLINE OVARIAN TUMOR; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DENMARK; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; OUTCOME ASSESSMENT; OVARY CANCER; OVARY CARCINOMA; PATIENT HISTORY OF BILATERAL OVARIECTOMY; PELVIC INFLAMMATORY DISEASE; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE HISTORY; RISK FACTOR; RISK REDUCTION; SALPINGECTOMY; UTERINE TUBE LIGATION; AGE DISTRIBUTION; CANCER STAGING; CONFIDENCE INTERVAL; INCIDENCE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; REGISTER; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TUMOR INVASION; UTERINE TUBE STERILIZATION; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DENMARK; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; ODDS RATIO; OVARIAN NEOPLASMS; REGISTRIES; RISK REDUCTION BEHAVIOR; SALPINGECTOMY; STERILIZATION, TUBAL;

EID: 84919338058     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12516     Document Type: Article

References (31)

1. Scully RE,. Classification of human ovarian tumors. Environ Health Perspect. 1987; 73: 15-25.
2. Prat J,. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012; 460: 237-49.
3. Kurman RJ, Shih I,. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010; 34: 433-43.
4. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007; 31: 161-9.
5. Cibula D, Widschwendter M, Majek O, Dusek L,. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update. 2011; 17: 55-67.
6. Rice MS, Murphy MA, Tworoger SS,. Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis. J Ovarian Res. 2012; 5: 13.
7. Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol. 2013; 42: 579-89.
8. Cibula D, Widschwendter M, Zikan M, Dusek L,. Underlying mechanisms of ovarian cancer risk reduction after tubal ligation. Acta Obstet Gynecol Scand. 2011; 90: 559-63.
9. Rice MS, Murphy MA, Vitonis AF, Cramer DW, Titus LJ, Tworoger SS, et al. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study. Int J Cancer. 2013; 133: 2415-21.
10. Kjaer SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH,. Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol. 2004; 33: 596-602.
11. Kreiger N, Sloan M, Cotterchio M, Parsons P,. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol. 1997; 26: 710-5.
12. Anderson CK, Wallace S, Guiahi M, Sheeder J, Behbakht K, Spillman MA,. Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer. Int J Gynecol Cancer. 2013; 23: 417-21.
13. Pedersen CB,. The Danish Civil Registration System. Scand J Public Health. 2011; 39: 22-5.
14. Gjerstorff ML,. The Danish Cancer Registry. Scand J Public Health. 2011; 39: 42-5.
15. The Danish Pathology Databank [continuously updated; cited 2013 Aug 15]. Copenhagen, 2013. Available online at: http://www.patobank.dk (accessed August 15, 2013).
16. Lynge E, Sandegaard JL, Rebolj M,. The Danish National Patient Register. Scand J Public Health. 2011; 39: 30-3.
17. Kildemoes HW, Sorensen HT, Hallas J,. The Danish National Prescription Registry. Scand J Public Health. 2011; 39: 38-41.
18. ATC Classification Index with DDDs. World Health Organization Collaborating Centre for Drug Statistics Methodology. Oslo, 2013. Available online at: http://www.whocc.no/atc-ddd-index/ (accessed August 15, 2013).
19. Blenstrup LT, Knudsen LB,. Danish registers on aspects of reproduction. Scand J Public Health. 2011; 39: 79-82.
20. Rothman K, Greenland S, Lash TL,. Case-control studies. In:, Rothman K, Greenland S, Lash TL, (eds). Modern epidemiology, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2008. pp. 111-27.
21. Kjer JJ,. Sterilisation af kvinder. [Female sterilization]. (in Danish. No abstract available.) Ugeskr Laeger. 2004; 166: 696-7.
22. Thranov I, Kjersgaard AG, Rasmussen OV, Hertz J,. Regret among 547 Danish sterilized women. Scand J Soc Med. 1988; 16: 41-8.
23. Riman T, Persson I, Nilsson S,. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol. 1998; 49: 695-707.
24. Cramer DW, Xu H,. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol. 1995; 5: 310-4.
25. Kurian AW, Balise RR, McGuire V, Whittemore AS,. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol. 2005; 96: 520-30.
26. Kurman RJ, Shih I,. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol. 2011; 42: 918-31.
27. Mills PK, Riordan DG, Cress RD,. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol. 2004; 95: 215-25.
28. Prat J,. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Mod Pathol. 2005; 18: 99-111.
29. McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014; 210: 471.
30. Lessard-Anderson C, Molitor R, Sauver JSt, Steckelberg K, Weaver A, Bakkum-Gamez J, et al. The impact of tubal sterilization techniques on the risk of serous ovarian and primary peritoneal carcinoma: A Rochester Epidemiology Project (REP) study. Abstract number 62 presented ad the 2013 Annual Meeting of the Society of Gynecologic Oncology, 2013 March 9-12, Los Angeles.
31. Chene G, Rahimi K, Mes-Masson AM, Provencher D,. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. J Minim Invasive Gynecol. 2013; 20: 153-9.